CN104983714A - Celecoxib capsule and preparing method thereof - Google Patents

Celecoxib capsule and preparing method thereof Download PDF

Info

Publication number
CN104983714A
CN104983714A CN201510473449.4A CN201510473449A CN104983714A CN 104983714 A CN104983714 A CN 104983714A CN 201510473449 A CN201510473449 A CN 201510473449A CN 104983714 A CN104983714 A CN 104983714A
Authority
CN
China
Prior art keywords
celebret
celecoxib
capsule
preparation
dry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510473449.4A
Other languages
Chinese (zh)
Inventor
张健
姚婵艳
钟玫
陈学文
刘志
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Erye Pharmaceutical Co Ltd
Original Assignee
Suzhou Erye Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Erye Pharmaceutical Co Ltd filed Critical Suzhou Erye Pharmaceutical Co Ltd
Priority to CN201510473449.4A priority Critical patent/CN104983714A/en
Publication of CN104983714A publication Critical patent/CN104983714A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a celecoxib capsule and a preparing method thereof. The celecoxib capsule is composed of celecoxib, lactose, croscarmellose sodium, povidone K30, lauryl sodium sulfate, a 2% sodium dodecyl sulfate solution and magnesium stearate. By means of the celecoxib capsule, the dissolution rate of the celecoxib is greatly increased, the stability of preparations is good, equipment is simple, and the celecoxib capsule is very suitable for industrial production.

Description

A kind of Celebret and preparation method thereof
Technical field
The present invention relates to pharmaceutical field, be specifically related to a kind of Celebret and preparation method.
Background technology
Celecoxib (celecoxib) is first specificity COX-2 (COX-2) inhibitor of Xi Er company of U.S. exploitation, for the treatment of osteoarthritis and rheumatoid arthritis, is the maximum non_steroidal anti_inflammatory drug of current global recipe quantity.
Celecoxib is white to off-white color crystalline powder, almost insoluble in water, belongs to insoluble drug.In order to improve the stripping of celecoxib, technical staff have employed different solutions, raw material is made undefined structure or solid dispersion is conventional method.But due to crystal structure, make the physicochemical property of celecoxib show as the preparation processability of extreme difference.This characteristic shows as: the first, almost insoluble in water, if directly by without the medicine filled capsules pulverized, Oral drug absorption will be caused very slow, affect bioavailability; Second, quality is light, bulk density is low, easy cohesion in bulk, causes the method adopting micromill process to improve dissolubility and bioavailability to become very difficult, when it mixes with adjuvant, also easy coalescent in bulk, be separated with adjuvant, not only cause preparation medicine uniformity of dosage units defective, and impact absorbs.
Have capsule at the celecoxib preparation of China list marketing at present, specification is 0.1g, 0.2g.The wet granulation that the many employings of capsule are traditional, production process is more, mainly through supplementary material mixing, prepare soft material, granulation, drying, arrangement, total mixed, filling, polishing, bubble-cap, operation is relatively loaded down with trivial details, consuming time longer.Make celecoxib in process of production variable color deterioration happen occasionally, it is large that medicine quality homogeneity controls difficulty, and between batch, quality fluctuation is remarkable, is unfavorable for patient safety medication.
Summary of the invention
In order to solve the problem of celecoxib preparation difficulty in prior art, the invention provides a kind of new Celebret and preparation method thereof.
First aspect, the present invention relates to a kind of Celebret, consists of the following composition:
Be preferably:
Or consist of:
Be preferably:
On the other hand, the present invention relates to a kind of preparation method of Celebret:
(1) celecoxib raw material pulverizer is crushed to D90≤15 μm, for subsequent use;
(2) take lactose, cross-linking sodium carboxymethyl cellulose, sodium lauryl sulphate and polyvidone k30 by recipe quantity, join mix homogeneously in Fastmixinggranulator;
(3) wet method soft material is carried out with 2% sodium dodecyl sulfate solution;
(4) oscillating granulator 30 order carries out wet granular granulate;
Dry in (5) 60 DEG C of air dry ovens, control moisture <2%;
(6) oscillating granulator carries out 30 mesh sieve granulate;
(7) dry granule and recipe quantity magnesium stearate are joined in LSD-50 moulding mixture bucket mixer, mixing;
(8) fill capsule.
Celebret of the present invention not only substantially increases the dissolution of celecoxib, and better stability of preparation, and equipment is simple, is very applicable to commercial production.
Accompanying drawing explanation
Fig. 1 is the process chart of the Celebret in the present invention
Detailed description of the invention
embodiment 1the preparation of 100mg specification Celebret
Table 1,100mg specification Celebret prescription
Supplementary material is taken according to the prescription proportioning of table 1; Celecoxib raw material pulverizer is crushed to D90≤15 μm, for subsequent use; Take lactose, cross-linking sodium carboxymethyl cellulose, sodium lauryl sulphate and polyvidone k30, to join in Fastmixinggranulator mix homogeneously in mixer; Wet method soft material is carried out with 2% sodium dodecyl sulfate solution; Oscillating granulator 30 order carries out wet granular granulate; Dry in 60 DEG C of air dry ovens, control moisture <2%; Oscillating granulator carries out 30 mesh sieve granulate; Dry granule and recipe quantity magnesium stearate are joined in LSD-50 moulding mixture bucket mixer, mixing; Intermediate detects; Fill capsule, packaging; Quan Jian, warehouse-in.
Table 2,100mg specification Celebret preparation technology parameter
embodiment 2specification is 200mg
Table 3,200mg specification Celebret prescription
Preparation method is with reference to embodiment 1.
embodiment 3inspection
Table 4, inspection item
Result shows that this preparation technology favorable reproducibility, method are feasible, with laboratory indices no significant difference, made sample passes, stable yield, can realize workshop and amplify production.

Claims (5)

1. a Celebret, it consists of:
2. Celebret as claimed in claim 1, its composition is preferably:
3. a Celebret, it consists of:
4. Celebret as claimed in claim 3, its composition is preferably:
5. the preparation method of the Celebret described in any one of claim 1-4, it comprises the steps:
Celecoxib raw material pulverizer is crushed to D90≤15 μm, for subsequent use;
Take lactose, cross-linking sodium carboxymethyl cellulose, sodium lauryl sulphate and polyvidone k30 by recipe quantity, join mix homogeneously in Fastmixinggranulator;
Wet method soft material is carried out with 2% sodium dodecyl sulfate solution;
Oscillating granulator 30 order carries out wet granular granulate;
Dry in 60 DEG C of air dry ovens, control moisture <2%;
Oscillating granulator carries out 30 mesh sieve granulate;
Dry granule and recipe quantity magnesium stearate are joined in LSD-50 moulding mixture bucket mixer, mixing;
Fill capsule.
CN201510473449.4A 2015-08-06 2015-08-06 Celecoxib capsule and preparing method thereof Pending CN104983714A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510473449.4A CN104983714A (en) 2015-08-06 2015-08-06 Celecoxib capsule and preparing method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510473449.4A CN104983714A (en) 2015-08-06 2015-08-06 Celecoxib capsule and preparing method thereof

Publications (1)

Publication Number Publication Date
CN104983714A true CN104983714A (en) 2015-10-21

Family

ID=54295705

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510473449.4A Pending CN104983714A (en) 2015-08-06 2015-08-06 Celecoxib capsule and preparing method thereof

Country Status (1)

Country Link
CN (1) CN104983714A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105232494A (en) * 2015-11-11 2016-01-13 青岛百洋制药有限公司 Celecoxib capsules and production technology thereof
CN107115313A (en) * 2017-07-03 2017-09-01 福建省福抗药业股份有限公司 A kind of celecoxib composition and preparation method thereof
CN112263562A (en) * 2020-09-25 2021-01-26 石药集团欧意药业有限公司 Preparation method of celecoxib capsule composition
CN113028740A (en) * 2021-04-29 2021-06-25 江苏优扬药业有限公司 Low-temperature drying device and method for pharmaceutic adjuvant

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1288378A (en) * 1998-11-30 2001-03-21 G·D·西尔公司 Celecoxib compositions
US20030004128A1 (en) * 1999-12-20 2003-01-02 Charanjit Bountra Formulatios of adenosine a1 agonists
CN102949402A (en) * 2011-08-24 2013-03-06 天津药物研究院 Celecoxib composition, and preparation method and use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1288378A (en) * 1998-11-30 2001-03-21 G·D·西尔公司 Celecoxib compositions
US20030004128A1 (en) * 1999-12-20 2003-01-02 Charanjit Bountra Formulatios of adenosine a1 agonists
CN102949402A (en) * 2011-08-24 2013-03-06 天津药物研究院 Celecoxib composition, and preparation method and use thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105232494A (en) * 2015-11-11 2016-01-13 青岛百洋制药有限公司 Celecoxib capsules and production technology thereof
CN107115313A (en) * 2017-07-03 2017-09-01 福建省福抗药业股份有限公司 A kind of celecoxib composition and preparation method thereof
CN112263562A (en) * 2020-09-25 2021-01-26 石药集团欧意药业有限公司 Preparation method of celecoxib capsule composition
CN113028740A (en) * 2021-04-29 2021-06-25 江苏优扬药业有限公司 Low-temperature drying device and method for pharmaceutic adjuvant

Similar Documents

Publication Publication Date Title
CN104983714A (en) Celecoxib capsule and preparing method thereof
CN100396278C (en) Medicinal micro pill core and its preparing method
CN104306344B (en) A kind of Azilsartan tablet and preparation technology thereof
CN107823170A (en) A kind of valsartan amlodipine piece and preparation method thereof
CN103735529A (en) Preparation method of amoxil dry-method granulated capsules
CN104983732A (en) Allergy and congestion relief and preparation method thereof
CN102895203A (en) Method for preparing azithromycin dispersible tablets
CN109953987A (en) A kind of valsartan amlodipine piece and preparation method thereof
CN106176639A (en) A kind of method preparing Roflumilast tablet
CN104688743B (en) Cefprozil suspension and preparation method thereof
CN106539769A (en) A kind of Lurasidone tablet and preparation method thereof
CN109953969A (en) A kind of preparation method of valsartan amlodipine piece
CN106265548A (en) A kind of preparation method of carbamazepine dispersible tablet
CN105030711A (en) Preparation method of Azilsartan tablets
CN105596311A (en) Riociguat oral solid preparation and preparing method thereof
EP3328603A1 (en) A process and apparatus for continuous granulation of powder material
CN104027319A (en) Celecoxib dispersible tablet and preparation method thereof
CN102166361A (en) Quick-collapsed type pellet core and preparation method thereof
CN117045608A (en) Quick-release preparation of vitamin B2 and preparation method thereof
CN109464401A (en) A kind of method of granulating suitable for viscous material
CN103690557A (en) Compound polyethylene glycol electrolyte composition
CN105997916A (en) Carbamazepine tablet and preparation method thereof
KR101155099B1 (en) Manufacturing method of composition for bowel cleansing and composition for bowel cleansing manufactured by thereof
CN106913556B (en) Rifapentine capsule and preparation method thereof
CN105919958A (en) Preparation method of lenalidomide capsules

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20151021

RJ01 Rejection of invention patent application after publication